Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

NEOPHAM 6.4%

AMINO ACIDS

Standard Dose
6.4% (6.4GM/100ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview NEOPHAM 6.4% is listed in Drugs@FDA under application 018792 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMINO ACIDS Form and strength INJECTABLE;INJECTION - 6.4% (6.4GM/100ML) Sponsor HOSPIRA Submission history Latest submission status date: 1995-02-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEOPHAM 6.4% is listed in Drugs@FDA under application 018792 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMINO ACIDS Form and strength INJECTABLE;INJECTION - 6.4% (6.4GM/100ML) Sponsor HOSPIRA Submission history Latest submission status date: 1995-02-09 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.